• Research Associate II - Bench, Immunity & Immunotherapies

    Job ID 2018-29206
    Area of Interest
    Research & Development
    Location Name
    Jack R MacDonald Building
    FTE/Hours per pay period
    1.0 FTE (80 hours per bi-weekly pay periods)
    Work Status
    Limited Term
    Immunity & Immunotherapies
    Day Shift
  • Overview

    Here at Seattle Children's we are united by a compelling mission: We provide hope, care and cures to help every child to live the healthiest and most fulfilling life possible. Seattle Children's Research Institute is among the top in National Institutes of Health funding - a sign that our physician-scientists are leaders in research that improves the outlook for children with a wide range of conditions.


    Come join our team!


    This position is for 6-24 months with funding renewed annually. 


    This position is expeced to be in the lab 80% of the time. 


    The Zheng Lab is looking for a highly motivated candidate to join our clinical study on the inflammable bowel disease (IBD) including Crohn’s Disease and Ulcerative Colitis. Successful candidates will have strong bench background on molecular biology techniques, DNA/RNA analysis, cDNA library construction, NextGen sequencing, etc. We are looking for an accountable team player with meticulous organizational skills, attention to detail, strong work ethics, and ability to learn quickly. This position will work closely with other clinical and lab team members, under supervision of the Lab Manager and PI. Responsibilities include tissue and blood sample processing, 10x single cell analysis, cDNA library construction, flow cytometry, and managing biorepository


    Seattle Children's Employer Highlights

    • Leader in Pediatric Care: Because of our people, Seattle Children's is recognized as a leading teaching, research and specialty care center at the forefront of pediatric care.
    • Employee Centric: Rated #10 on Forbes Best Employer listin 2016
    • Competitive Benefits: We support a healthy work-life balance. Our benefits include employee care, paid time off, health insurance and retirement savings.
    • Transportation Discounts: Company bike program, on-site zip cars, unlimited ORCA transit pass, daily commute bonus provided to staff who us alternate methods of travel to/from work, company vanpools.
    • Diversity/Inclusion: We strive to maintain an atmosphere that reflects our values of inclusion by providing effective and respectful care compatible with each patient and family's beliefs, values, and heritage


    Want to know what it is like to work at Seattle Children's? Read more about our culture or check out our TheMuse page for an inside look into Seattle Children's.

    This position is for 6-24 months with funding renewed annually. 


    Required Education/Experience:
    - Bachelor’s Degree in Microbiology, Biochemistry, Immunology, or related field
    - At least five (5) years laboratory experience, including previous experience with techniques in flow cytometry.

    - Master’s Degree in Microbiology, Biochemistry, Immunology, or related field
    - Previous experience in histology, fluorescence microscopy, and real-time quantitative PCR
    - Familiarity with computers, and experience analyzing datausing spreadsheets and statistical analysis.


    Knowledge, Skills, and Abilities:

    - Knowledge of molecular and cell biology, and strong background on mocular biology techniques and procedures

    - Knowledge of biosafety rules and safe handling protocols for hazardous materials

    - Good at data collection and analysis, and record keeping

    - Strong communication and interpersonal skills, able to work collaboratively in a team environment

    - Strong organization skills, problem-solving skills, and detail oriented

    - Able to work with flexible hours, sometimes in the late afternoon and evening as needed

    - Able to respond effectively with sudden requests, handling them in an efficient/timely manner


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed